| 2026 | | Correction: Peptide‑based therapeutics targeting the SLC39A14‑PIWIL2 fusion in hepatocellular carcinoma
Genomics & informatics, 24(1). : 5-5, 2026 | SHAH, MASAUD, 우현구, 최지혜 |
| 2025 | | Peptide‑based therapeutics targeting the SLC39A14‑PIWIL2 fusion in hepatocellular carcinoma
Genomics & informatics, 23(1). : 28-28, 2025 | SHAH, MASAUD, 우현구, 최지혜 |
| 2025 | | BIGPN: Biologically informed graph propagational network for plasma proteomic profiling of neurodegenerative biomarkers
Artificial intelligence in medicine, 169. : 103241-103241, 2025 | SHAH, MASAUD, 우현구 |
| 2025 | | Pan-Variant SARS-CoV-2 Vaccines Induce Protective Immunity by Targeting Conserved Epitopes
Advanced science (Weinheim, Baden-Württemberg, Germany), 12(16). : e2409919-e2409919, 2025 | SHAH, MASAUD, 김도윤, 신지연, 우현구, 최지혜 |
| 2025 | | Integrative transcriptomic and genomic analyses unveil the IFI16 variants and expression as MASLD progression markers
Hepatology (Baltimore, Md.), 81(3). : 962-975, 2025 | SHAH, MASAUD, 김도윤, 우현구 |
| 2025 | | Structural insights into antibody-based immunotherapy for hepatocellular carcinoma
Genomics & informatics, 23(1). : 1-1, 2025 | SHAH, MASAUD, 우현구 |
| 2025 | | Leveraging deep transfer learning and explainable AI for accurate COVID-19 diagnosis: Insights from a multi-national chest CT scan study
Computers in biology and medicine, 185. : 109461-109461, 2025 | SHAH, MASAUD, 우현구 |
| 2024 | | Challenges and considerations in multi-epitope vaccine design surrounding toll-like receptors
Trends in pharmacological sciences, 45(12). : 1104-1118, 2024 | SHAH, MASAUD, 우현구 |
| 2024 | | Long Non-coding RNA TPRG1-AS1 Interacts With CLTC in Liver Cancer Cells
Anticancer research, 44(11). : 4813-4824, 2024 | SHAH, MASAUD, 우현구 |
| 2024 | | RRM2 Is a CTNNB1 Transport Regulator Promoting Colon Cancer Progression
Anticancer research, 44(6). : 2471-2485, 2024 | SHAH, MASAUD, 우현구 |
| 2024 | | Differential glycosylation in mutant vitamin D-binding protein decimates the binding stability of vitamin D
Journal of biomolecular structure & dynamics, 42(10). : 5365-5375, 2024 | SHAH, MASAUD |
| 2023 | | Assessment of neutralization susceptibility of Omicron subvariants XBB.1.5 and BQ.1.1 against broad-spectrum neutralizing antibodies through epitopes mapping
Frontiers in molecular biosciences, 10. : 1236617-1236617, 2023 | SHAH, MASAUD, 우현구 |
| 2023 | | Novel polyhydroquinoline Schiff’s base derivatives: synthesis, characterization, in vitro α-glucosidase inhibitory, and molecular docking studies
Research on chemical intermediates, 49(7). : 3005-3028, 2023 | SHAH, MASAUD |
| 2023 | | Rational strategies for enhancing mAb binding to SARS-CoV-2 variants through CDR diversification and antibody-escape prediction
Frontiers in immunology, 14. : 1113175-1113175, 2023 | SHAH, MASAUD, 우현구 |
| 2022 | | Isolation, cloning and transgenic expression of hepatitis B surface antigen (HBsAg) in Solanum lycopersicum L
Saudi journal of biological sciences, 29(3). : 1559-1564, 2022 | SHAH, MASAUD |
| 2022 | | Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies
Frontiers in immunology, 12. : 830527-830527, 2022 | SHAH, MASAUD, 우현구 |
| 2022 | | The paradigm of immune escape by SARS-CoV-2 variants and strategies for repositioning subverted mAbs against escaped VOCs
Molecular therapy, 30(10). : 3101-3105, 2022 | SHAH, MASAUD, 우현구 |
| 2022 | | SARS-CoV-2 pan-variant inhibitory peptides deter S1-ACE2 interaction and neutralize delta and omicron pseudoviruses
Computational and structural biotechnology journal, 20. : 2042-2056, 2022 | SHAH, MASAUD, 문승욱, 우현구 |
| 2021 | | Molecular perspectives of SARS-CoV-2: Pathology, immune evasion, and therapeutic interventions
Molecules and cells, 44(6). : 408-421, 2021 | SHAH, MASAUD, 우현구 |
| 2021 | | TPRG1-AS1 induces RBM24 expression and inhibits liver cancer progression by sponging miR-4691-5p and miR-3659
Liver international, 41(11). : 2788-2800, 2021 | SHAH, MASAUD, 우현구, 최지혜 |
| 2021 | | USO1 isoforms differentially promote liver cancer progression by dysregulating the ER-Golgi network
Carcinogenesis, 42(9). : 1208-1220, 2021 | SHAH, MASAUD, 권소미, 우현구, 최지혜 |
| 2020 | | Mutations in the SARS-CoV-2 spike RBD are responsible for stronger ACE2 binding and poor anti-SARS-CoV mAbs cross-neutralization
Computational and structural biotechnology journal, 18. : 3402-3414, 2020 | SHAH, MASAUD, 우현구 |
